InfuSystem Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Business Segment Information (Tables)

Note 14 - Business Segment Information (Tables)

6 Months Ended

Jun. 30, 2021

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

2021
										Corporate/
*(in thousands)*		ITS				DME Services				Eliminations				Total

Net revenues - external		$	16,334			$	8,500			$	-			$	24,834
Net revenues - internal			-				1,598				(1,598	)			-
Total net revenues			16,334				10,098				(1,598	)			24,834
Gross profit			10,451				4,599				-				15,050

Selling, general and administrative expenses											14,354				14,354
Interest expense											(317	)			(317	)
Other expense											(37	)			(37	)
Benefit from income taxes											478				478

Net income														$	820

Total assets		$	60,876			$	33,121			$	2,000			$	95,997
Purchases of medical equipment		$	1,871			$	736			$	-			$	2,607
Depreciation and amortization of intangible assets		$	2,732			$	927			$	-			$	3,659

2020
										Corporate/
*(in thousands)*		ITS				DME Services				Eliminations				Total

Net revenues - external		$	15,605			$	10,394			$	-			$	25,999
Net revenues - internal			-				1,258				(1,258	)			-
Total net revenues			15,605				11,652				(1,258	)			25,999
Gross profit			10,279				5,699				-				15,978

Selling, general and administrative expenses											11,472				11,472
Interest expense											(332	)			(332	)
Other expense											(9	)			(9	)
Provision for income taxes											(25	)			(25	)

Net income														$	4,140

Total assets		$	51,962			$	30,007			$	2,000			$	83,969
Purchases of medical equipment		$	2,663			$	2,113			$	-			$	4,776
Depreciation and amortization of intangible assets		$	2,694			$	836			$	-			$	3,530

2021
										Corporate/
*(in thousands)*		ITS				DME Services				Eliminations				Total

Net revenues - external		$	32,245			$	17,052			$	-			$	49,297
Net revenues - internal			-				3,044				(3,044	)			-
Total net revenues			32,245				20,096				(3,044	)			49,297
Gross profit			20,454				9,172				-				29,626

Selling, general and administrative expenses											28,057				28,057
Interest expense											(639	)			(639	)
Other expense											(106	)			(106	)
Benefit from income taxes											657				657

Net income														$	1,481

Total assets		$	60,876			$	33,121			$	2,000			$	95,997
Purchases of medical equipment		$	3,492			$	1,451			$	-			$	4,943
Depreciation and amortization of intangible assets		$	5,428			$	1,801			$	-			$	7,229

2020
										Corporate/
*(in thousands)*		ITS				DME Services				Eliminations				Total

Net revenues - external		$	29,731			$	17,821			$	-			$	47,552
Net revenues - internal			-				2,496				(2,496	)			-
Total net revenues			29,731				20,317				(2,496	)			47,552
Gross profit			19,385				9,256				-				28,641

Selling, general and administrative expenses											24,102				24,102
Interest expense											(735	)			(735	)
Other expense											(28	)			(28	)
Provision for income taxes											(54	)			(54	)

Net income														$	3,722

Total assets		$	51,962			$	30,007			$	2,000			$	83,969
Purchases of medical equipment		$	5,020			$	3,763			$	-			$	8,783
Depreciation and amortization of intangible assets		$	5,348			$	1,584			$	-			$	6,932